Browsing by Subject "NAD(+)"
Now showing items 1-1 of 1
-
FK866 compromises mitochondrial metabolism and adaptive stress responses in cultured cardiomyocytes (Elsevier, 2015)Aim: FK866 is an inhibitor of the NAD(+) synthesis rate-limiting enzyme nicotinamide phosphoribosyltransferase (NAMPT). Using FK866 to target NAD(+) synthesis has been proposed as a treatment for inflammatory diseases and ...